vs
Side-by-side financial comparison of FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI) and Silexion Therapeutics Corp (SLXN). Click either name above to swap in a different company.
FARADAY FUTURE INTELLIGENT ELECTRIC INC. is the larger business by last-quarter revenue ($129.0K vs $70.0K, roughly 1.8× Silexion Therapeutics Corp). Silexion Therapeutics Corp runs the higher net margin — -6302.9% vs -26011.6%, a 19708.8% gap on every dollar of revenue. Silexion Therapeutics Corp produced more free cash flow last quarter ($-3.0M vs $-29.5M).
Faraday Future Inc. is an American technology company founded in 2014 focused on the development of electric vehicles. Based in Los Angeles, California, it began producing vehicles in 2023 and markets them in the United States and China. The company delivered a total of 16 vehicles by January 2025. After two funding rounds in late 2024 totaling $60 million, the company announced it will pivot to selling rebadged Chinese vans.
Silexion Therapeutics Corp is a clinical-stage biopharmaceutical firm developing innovative targeted therapies for autoimmune, inflammatory, and immunological diseases. It serves North American and global healthcare markets, with R&D focused on novel biologic candidates addressing unmet patient medical needs.
FFAI vs SLXN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $129.0K | $70.0K |
| Net Profit | $-33.6M | $-4.4M |
| Gross Margin | -12111.6% | — |
| Operating Margin | -25041.9% | -6294.3% |
| Net Margin | -26011.6% | -6302.9% |
| Revenue YoY | -45.1% | — |
| Net Profit YoY | 72.3% | — |
| EPS (diluted) | — | $1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $129.0K | $70.0K | ||
| Q3 25 | — | $39.0K | ||
| Q2 25 | — | $44.0K | ||
| Q1 25 | $316.0K | — | ||
| Q4 24 | $235.0K | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $293.0K | — | ||
| Q4 23 | $233.0K | — |
| Q4 25 | $-33.6M | $-4.4M | ||
| Q3 25 | — | $-3.3M | ||
| Q2 25 | — | $-2.5M | ||
| Q1 25 | $-10.3M | — | ||
| Q4 24 | $-121.3M | — | ||
| Q3 24 | — | $-11.9M | ||
| Q2 24 | $-108.7M | — | ||
| Q4 23 | $-83.8M | — |
| Q4 25 | -12111.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -6666.1% | — | ||
| Q4 24 | -8801.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -7057.0% | — | ||
| Q4 23 | -8424.9% | — |
| Q4 25 | -25041.9% | -6294.3% | ||
| Q3 25 | — | -8441.0% | ||
| Q2 25 | — | -5190.9% | ||
| Q1 25 | -13870.6% | — | ||
| Q4 24 | -12899.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -17272.7% | — | ||
| Q4 23 | -29090.1% | — |
| Q4 25 | -26011.6% | -6302.9% | ||
| Q3 25 | — | -8364.1% | ||
| Q2 25 | — | -5688.6% | ||
| Q1 25 | -3252.5% | — | ||
| Q4 24 | -51599.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -37093.9% | — | ||
| Q4 23 | -35964.4% | — |
| Q4 25 | — | $1.50 | ||
| Q3 25 | — | $2.88 | ||
| Q2 25 | — | $4.32 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $274.25 | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.9M | $6.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-27.3M | $2.6M |
| Total Assets | $277.9M | $7.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.9M | $6.0M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | $9.5M | — | ||
| Q4 24 | $7.1M | — | ||
| Q3 24 | — | $2.0M | ||
| Q2 24 | $793.0K | — | ||
| Q4 23 | $1.9M | — |
| Q4 25 | $-27.3M | $2.6M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | — | $120.0K | ||
| Q1 25 | $139.8M | — | ||
| Q4 24 | $115.0M | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | $148.7M | — | ||
| Q4 23 | $228.2M | — |
| Q4 25 | $277.9M | $7.2M | ||
| Q3 25 | — | $11.6M | ||
| Q2 25 | — | $5.8M | ||
| Q1 25 | $410.6M | — | ||
| Q4 24 | $425.4M | — | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | $457.9M | — | ||
| Q4 23 | $530.5M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.4M | $-3.0M |
| Free Cash FlowOCF − Capex | $-29.5M | $-3.0M |
| FCF MarginFCF / Revenue | -22886.8% | -4311.4% |
| Capex IntensityCapex / Revenue | 867.4% | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-91.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-28.4M | $-3.0M | ||
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $-2.5M | ||
| Q1 25 | $-20.3M | — | ||
| Q4 24 | $-18.4M | — | ||
| Q3 24 | — | $-2.7M | ||
| Q2 24 | $-14.4M | — | ||
| Q4 23 | $-37.8M | — |
| Q4 25 | $-29.5M | $-3.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-2.5M | ||
| Q1 25 | $-21.9M | — | ||
| Q4 24 | $-25.3M | — | ||
| Q3 24 | — | $-2.7M | ||
| Q2 24 | $-14.6M | — | ||
| Q4 23 | $-58.1M | — |
| Q4 25 | -22886.8% | -4311.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -5700.0% | ||
| Q1 25 | -6918.7% | — | ||
| Q4 24 | -10770.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4993.5% | — | ||
| Q4 23 | -24923.2% | — |
| Q4 25 | 867.4% | 2.9% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | 496.2% | — | ||
| Q4 24 | 2945.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 88.4% | — | ||
| Q4 23 | 8696.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
